Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001819790-25-000081
Filing Date
2025-06-11
Accepted
2025-06-11 16:50:49
Documents
3
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749675042.html 4  
1 FORM 4 wk-form4_1749675042.xml 4 3884
2 EX-24 tarsus-powerofattorneyse.htm EX-24 4293
3 tarsus-powerofattorneyse001.jpg GRAPHIC 221178
  Complete submission text file 0001819790-25-000081.txt   314335
Mailing Address 233 WILSHIRE BOULEVARD SUITE 280 SANTA MONICA CA 90401
Business Address
Mottiwala Aziz (Reporting) CIK: 0001788542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 251040639

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)